TRACON Pharmaceuticals chief business officer to resign
Insight Weekly: Loan-to-deposit ratio rises; inventory turnovers ebb; miners add female leaders
Debt Ceiling Debate: IR Teams Should Prepare for Potential Market Downturns
Insight Weekly: Sustainable bonds face hurdles; bad loans among landlords; AI investments up
Insight Weekly: Bank oversight steps up; auto insurers’ dismal year; VC investment slumps
H. Casey Logan plans to resign as chief business officer of TRACON Pharmaceuticals Inc., effective March 2, to pursue a new professional opportunity.
Logan's resignation is not a result of any disagreement with the company.
